Skip to main content
    E

    EUDA Health Holdings Limited (EUDA)

    Official site

    REAL ESTATE • REAL ESTATE SERVICES • NASDAQ

    $15.01
    -0.54 (-3.47%)

    Market Cap: $46.56M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    EUDA Health Holdings Limited (EUDA) Financials: Revenue, Profit and Cash Flow

    Updated Jul 28, 2026. Financial statements from company filings, amounts in US dollars.

    EUDA Health Holdings reported revenue of $6.82M for the fiscal year ended Dec 31, 2025, up 70.0% from the year before. That year, net income was -$2.77M with a net margin of -40.7%, operating cash flow was -$2.43M and free cash flow was -$2.53M. The quarter ended Jun 30, 2026 had revenue of $1.73M and net income of -$397.50K.

    Revenue and Margins

    The operating margin was -35.8% in the fiscal year ended Dec 2025, the lowest of the 3 years shown with an operating margin. Over the 5 years to Dec 2025, revenue fell from $8.88M, a compound annual decline of 5.1%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$6.82M+70.0%43.9%-35.8%-40.7%
    Dec 2024$4.01M+8.2%19.0%-432.2%-382.9%
    Dec 2023$3.71M-1.5%22.7%-106.9%-270.9%
    Dec 2022$3.76M-17.4%23.1%-151.9%-661.1%
    Dec 2021$4.56M-48.6%27.4%-12.3%19.0%
    Dec 2020$8.88MN/A43.8%-10.1%2.0%
    Annual, fiscal years ended Dec 2020 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Revenue$6.82M$4.01M$3.71M$3.76M$4.56M$8.88M
    Cost of revenue$3.83M$3.25M$2.86M$2.89M$3.31M$4.99M
    Gross profit$2.99M$762.15K$842.08K$870.00K$1.25M$3.89M
    Research and development$249$0$0$17.21K$129.26K$158.01K
    Operating income-$2.44M-$17.34M-$3.96M-$5.72M-$559.99K-$893.56K
    Net income-$2.77M-$15.36M-$10.04M-$24.88M$864.83K$175.57K
    EBITDA-$2.09MN/AN/AN/A$1.34M-$608.18K
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Revenue$1.73M$1.73M$1.88M$1.53M$1.05M$954.02K$1.11M$2.43M$2.43M$2.31M$2.43M$2.67M
    Gross profit$640.94K$640.94K$1.08M$417.66K$160.04K$221.04K$298.00K$817.63K$817.63K$604.68K$660.64K$1.27M
    Operating income-$380.77K-$380.77K-$672.91K-$566.09K-$495.06K-$8.17M-$2.06M-$9.67M-$8.53M-$298.33K-$1.23M$75.31K
    Net income-$397.50K-$397.50K-$784.38K-$602.00K$735.34K-$8.41M-$6.10M-$22.51M-$22.51M$201.01K-$1.86M-$472.99K
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, short-term debt of $2.33M exceeded cash and equivalents by $1.99M. Shareholder equity was negative, at -$4.25M, as total liabilities of $5.98M exceeded total assets of $1.72M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Total assets$1.72M$1.73M$1.31M$25.63M$8.00M$5.88M
    Current assets$1.04M$762.88K$723.44K$25.03M$4.35M$4.27M
    Cash and equivalents$345.14K$237.60K$189.00K$57.54K$190.00K$250.77K
    Total liabilities$5.98M$4.30M$8.79M$29.14M$7.40M$6.20M
    Short-term debt$2.33M$1.22M$3.30M$3.62M$428.65K$684.08K
    Shareholder equity-$4.25M-$2.55M-$7.50M-$3.52M$521.23K-$360.59K
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$9.68M$9.68M$1.72M$1.72MN/A$2.12M$1.70M$1.70M$2.03M$2.03M$1.31M$1.31M
    Total liabilities$3.72M$3.72M$5.98M$5.98MN/A$5.85M$4.27M$4.27M$8.04M$8.04M$8.79M$8.79M
    Cash and equivalents$365.90K$365.90K$345.14K$345.14KN/A$176.58K$237.60K$237.60K$376.21K$376.21K$189.00K$189.00K
    Shareholder equity$5.98M$5.98M-$4.25M-$4.25MN/A-$3.71M-$2.55M-$2.55M-$6.02M-$6.02M-$7.50M-$7.50M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Operating cash flow-$2.43M-$2.03M-$2.92M-$1.53M$443.92K-$411.88K
    Capital expenditures$104.45K$116.03K$5$18.14K$1.96K$76.06K
    Free cash flow-$2.53M-$2.15M-$2.92M-$1.54M$441.96K-$487.94K
    Dividends paidN/AN/AN/A$1.31MN/AN/A
    Investing cash flow-$104.45K-$147.77KN/A-$268.21K-$356.18K$179.34K
    Financing cash flow$2.55M$2.32M$2.35M$2.49M-$168.37K$212.51K
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Jun 2023Mar 2023Dec 2022
    Operating cash flow-$603.02K-$603.02K-$605.56K-$607.71K-$388.06K-$629.30K-$469.91K$667.48K$667.48K
    Capital expenditures$0$77.26K$27.02K$11.61K$47.80K$576$2$37$37
    Free cash flow-$603.02K-$680.28K-$632.58K-$619.32K-$435.87K-$629.88K-$469.91K$667.44K$667.44K
    Last 9 quarters

    Frequently Asked Questions About EUDA

    What is EUDA Health Holdings' annual revenue?

    EUDA Health Holdings reported revenue of $6.82M for the fiscal year ended Dec 31, 2025.

    How fast is EUDA Health Holdings' revenue growing?

    Revenue was up 70.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 21.9%.

    Is EUDA Health Holdings profitable?

    No. EUDA Health Holdings reported net income of -$2.77M for the fiscal year ended Dec 31, 2025, with a net margin of -40.7%.

    How much free cash flow does EUDA generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$2.43M minus capital expenditures of $104.45K produced free cash flow of -$2.53M.

    How much debt does EUDA Health Holdings have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $2.33M and cash and equivalents of $345.14K.